Biofil Chemicals Hits 52-Week Low as Stock Plummets to Rs 38

Biofil Chemicals & Pharmaceuticals has reached a significant milestone by touching its 52-week low of Rs 38 on November 6, 2025. This marks a notable decline for the microcap company, which has seen its stock price decrease by 5.14% over the past two days. On this trading day, the stock recorded an intraday low of Rs 38.6, reflecting a drop of 2.53%.
In terms of performance metrics, Biofil Chemicals has underperformed its sector by 1.9% today and has consistently traded below its moving averages across various time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. Over the past year, the stock has experienced a substantial decline of 43.81%, contrasting sharply with the Sensex, which has gained 3.74% during the same period.

Despite some positive quarterly results, including a highest PAT of Rs 2.41 crore and an EPS of Rs 1.48, the company's long-term fundamentals indicate weak growth, with a -25.47% CAGR in operating profits over the last five years. The current market conditions and the stock's performance suggest a challenging environment for Biofil Chemicals & Pharmaceuticals.